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	 The	study	was	conducted	with	the	purpose	to	develop	and	validate	a	high	performance	liquidchromatography	 method	 with	 UV	 detector	 to	 determine	 ketoprofen	 content	 in	 tablet
preparation	using	ethanol‐phosphate	buffer	(pH	=	6.0,	80:20,	v:v).	The	method	was	validated
toward	 parameters	 of	 accuracy,	 precision,	 linearity,	 selectivity,	 LOD	 and	 LOQ.	 The	 results
obtained	 fulfill	 the	 validation	 requirement	 of	 the	 ketoprofen	 tablet	 in	 the	 form	 of	 LOD	 =
0.5302	ppm	and	LOQ	=	1.7676	ppm.	
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1.	Introduction	
	
Ketoprofen	 is	 an	 non‐steroidal	 anti‐inflammation	 drug,	
used	in	this	study	by	considering	various	aspects	[1,2],	namely	
solubility,	weak	acid	compound	and	easily	dissolve,	in	ethanol,	
chloroform	 and	 ether	 [3].	 Ketoprofen	 dissolution	 can	 also	 be	
increased	by	adding	0.2	M	phosphate	buffer	with	pH	=	5‐7	up	to	
3‐105	times	compared	to	its	solubility	in	water	[4].	
High	 performance	 liquid	 chromatograph	 (HPLC)	 is	 often	
used	to	validate	method	of	analysis	by	first	optimizing	various	
parameters	 [5‐10].	 The	 optimization	 is	 important	 for	 the	
effectiveness	 and	 efficiency	 of	 instrument.	 The	 validation	
parameters	 reported	 in	 this	 paper	 are	 accuracy,	 precision,	
selectivity,	 detection	 limit,	 linearity,	 and	 robustness	 of	
validated	 for	 the	estimation	of	ketoprofen	standard	as	well	as	
tablet	dosage	form	[11,12].	
	
2.	Experimental	
	
HPLC	instruments	consist	of	phase	isokratil	type	Shimadzu	
brand	 version	 6.1	 joined	 with	 SCL‐10	 AVP	 control	 system,	
detector	UV‐VIS	SPD‐10	AMP,	pump	LC	10	ADVp,	oven	column	
CTO‐10	 ACVP.	 Shim‐pack	 column	 VP‐ODS	 250	 x	 4.6	 mm.	
Filtration	unit	for	HPLC	(Shibata),	ultrasonic	bath	(Shibata	type	
SU‐2	 TH),	 and	 spectrophotometer	 UV‐Vis	 (Shimadzu	 type	
1601).	 Ketoprofen	 tablet	 50	 mg	 from	 the	 factory	 sample,	
ketoprofen	standard	of	comparison	 from	PT	Pharos	with	LSA:	
14901595	and	gross	weight:	0.051	kg.	Difference:	0.001	kg,	Net	
weight:	 0.050	 kg,	 Phosphate	 buffer	 pH	 =	 5.6	 and	 7.0	 with	
degree	of	pro	analysis	reaction,	ethanol	99.99%	gradient	grade	
for	liquid	chromatography.	
	
	
2.1.	Preparation	of	Ketoprofen	standard	solution	
	
About	 10	 mg	 ketoprofen	 standard	 was	 weighed,	 then	
dissolved	with	ethanol	in	flask	of	10	mL	up	to	the	sign	limit,	and	
homogenized	 to	 obtain	 concentration	 of	 ketoprofen	 standard	
solution	1000	ppm.	
	
2.2.	Optimization	of	mobile	phase	volume	
	
Ketoprofen	 standard	 solution	 1000	ppm,	pipetted	 0.02mL	
was	put	into	the	flask	of	10	mL,	diluted	with	ethanol	up	to	the	
sign	 limit,	 then	 injected	as	much	as	25	μL	 into	 the	HPLC	with	
mix	mobile	phase	of	ethanol	phosphate	buffer	pH	=	5	(95:5,	v:v)	
using	 speed	 flow	 1	 mL/min	 with	 10	 minutes	 retention	 time.	
The	experiment	was	replicated	3	times	and	also	the	mix	mobile	
phase	 of	 ethanol	 phosphate	 buffer	 (90:10,	 v:v;	 85:15,	 v:v	 and	
80:20,	v:v),	 then	 the	mix	mobile	phase	was	 chosen	 to	provide	
the	best	separation	based	on	HETP	and	number	of	plats	theory	
(N).	
	
2.3.	Test	of	system	conformity	
	
Ketoprofen	 standard	 solution	 1000	 ppm	was	 pipetted	 0.2	
mL	and	put	into	the	flask	of	10	mL	and	diluted	with	ethanol	up	
to	 the	 sign	 limit,	 homogenized	 to	 obtain	 ketoprofen	 standard	
concentration	each	20	ppm	with	three	replications	made.	Then	
each	 replication	was	 injected	25	mL	 into	HPLC	with	optimum	
mix	mobile	phase,	optimum	pH	phosphate	buffer,	the	detector	
was	arranged	at	the	selected	wave	length	and	used	speed	flow	
1	 mL/min	 with	 10	 minutes	 retention	 time	 to	 obtain	
chromatogram	 for	 each	 concentration	 to	 be	 used	 in	
determining	 the	 repetition	of	 standard	solution	 change	 stated	
in	relative	standard	deviation.	
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Table	1.	 Accuracy	 of	 test	 result	method	 of	 standard	 additions	 of	 ketoprofen	 in	 the	 sample	 (concentration	 80%)	 in	 ethanol‐dafarfosfat	mobile	 phase	pH	=	6	
(80:20,	v:v)	(n=5).	
No	 Tablets	
(mg)	
Standard	
(mg)(CA)	
Sample	
(mg)(CA)	
Total	Ketoprofen	
(mg)	
Rt	
(minutes)	
Area	
(mAU*S)	
Content	
(CF)	
Recovery	
(%)	
1	 129	 13	 28.165	 41.165 6.517 16176097 41.237	 100.553
2	 129	 12	 28.165	 40.165 6.342 15709253 40.005	 98.666
3	 128	 12	 27.947	 39.947	 6.358	 15716001	 40.023	 100.633	
4	 130	 14	 28.384	 42.384	 6.392	 16653791	 42.497	 100.807	
5	 130	 14	 28.384	 42.384 6.250 16569073 42.273	 99.207
Average	 99.973
Standard	deviation		 0.752
%	Average	standard	deviation		 0.867	
	
	
Table	2.	Repeability	of	test	result	assay	of	ketoprofen	(a	concentration	of	20	ppm)	in	ethanol‐dafarfosfat	pH	=	6	(80:20,	v:v)	(n=5).	
No	 Area	(mAU*S)	 Peak	Height	(mAU)	
1	 5354423 374391
2	 5374777 375422
3	 5360187 372357
4	 5302888 374121
5	 5150702	 364068	
Average	 5322948 307021.8	
Standard	deviation		 96702.570 4608.250	
%	Average	standard	deviation		 1.739 1.238
	
	
Table	3.	Repeability	of	test	result	assay	of	ketoprofen	(a	concentration	of	100	ppm)	in	ethanol‐dafarfosfat	pH	=	6	(80:20,	v:v)	(n=5).	
No	 Area (mAU*S) Peak	Height	(mAU)	
1	 23835932 1610843	
2	 23703430 1630495	
3	 23252063 1635901	
4	 24447081	 1650709	
5	 23418695	 1692778	
Average	 23907026.8 1644145	
Standard	deviation		 477493.809 30706.53	
%	Average	standard	deviation		 1.944 1.867
	
	
	
		
Figure 1. Calibration	curve	by	Ketoprofen	by	HPLC.
	
	
2.4.	Linearity	
	
In	 order	 to	 determine	 linearity	 between	 ketoprofen	
concentration	 and	 size	 of	 area,	 the	 solution	 series	 were	
prepared:	 20,	 40,	 60,	 80	 and	 100	 ppm	 from	 ketoprofen	
standard	solution	1000	ppm.	The	 result	 can	provide	equation	
of	regression	line	y	=	236904.255	x	+	545295.9.	The	calculation	
of	 ketoprofen	 content	 used	 the	 equation	 line.	 The	 correlation	
value	 indicates	 that	 there	 is	 a	 good	 correlation	 between	
ketoprofen	concentration	and	the	size	of	area	(Figure	1).	
	
2.5.	Accuracy	
	
The	method	 applied	was	 the	 addition	 of	 sample	 standard	
and	then	analyzed.	The	difference	of	result	was	compared	with	
added	 standard	 content	 as	 percentage	 of	 re‐planning.	 The	
accuracy	method	 is	 said	 to	 be	 good	 if	 the	 range	of	 regain	98‐
102%	(Table	1).	
The	 recovery	 according	 to	 data	 was	 arranged	 with	
concentration	 80%	 each	 was	 replicated	 5	 times	 and	 the	
average	 obtained	 is	 99.973‐50.752	 %	 with	 range	 98.686‐
100.807	%	and	value	of	averagedeviation	standard	0.867.	
	
2.6.	Precision	
	
The	test	was	done	by	examining	low	concentration	as	much	
as	 20	 ppm	 and	 high	 concentration	 100	 ppm	 each	 was	
replicated	 5	 times	 in	 method	 range.	 By	 using	 the	 result	 of	
standard	dissolution	in	different	concentration,	the	size	of	area	
can	 be	 known	 and	peak	 height	 provided	 by	HPLC	 shows	 that	
the	 method	 used	 to	 determine	 ketoprofen	 content	 is	 precise	
since	the	Average	Deviation	Standard	of	reexamination	<	20%	
as	can	be	seen	in	Table	2	and	3.	
60	 Naid	et	al.	/	European	Journal	of	Chemistry	4	(1)	(2013)	58‐60	
	
	
Table	4.	Test	result	of	content	uniformity	of	Ketoprofen	inthe	factory	sample	50	mg	(n=10).	
No	 Tablets	(mg)	 Sample	(mg)	 Rt	(minutes) Area (mAU*S) Content	of	Ketoprofen	each	tablet Content	of	Ketoprofen (%)
1	 229	 50	 6.383	 18254098 46.719 93.438	
2	 231	 50	 6.433	 19217996	 49.262	 98.524	
3	 228	 50	 6.533	 20148247	 51.715	 103.431	
4	 239	 50	 6.533	 19148247	 49.078	 98.156	
5	 224	 50	 6.417	 19956240 51.209 102.419	
6	 231	 50	 6.650	 20342563 52.229 104.458	
7	 228	 50	 6.667	 18245556 46.696 93.393	
8	 230	 50	 6.683	 20229079 51.929 103.859	
9	 229	 50	 6.342	 18380439 47.052 94.105	
10	 230	 50	 6.308	 18221926 46.634 93.268	
Average	 49.252 98.5051	
Standard	deviation		 2.371 4.742	
%	Average	standard	deviation		 4.814 4.814	
	
	
Table	5.	Test	result	of	content	uniformity	of	Ketoprofen	in	the	factory	sample	50	mg	(n=6).	
No	 Tablets	(mg)	 Sample	(mg)	 Rt	(minutes)	 Area	(mAU*S)	 Content	of	Ketoprofen	each	tablet	 Content	of	Ketoprofen	(%)	
1	 229	 50	 6.700	 20196206 51.842 103.684	
2	 231	 50	 6.383	 19870053 50.982 101.964	
3	 230	 50	 6.675	 20047037 51.449 102.898	
4	 230	 50	 6.342	 20093247 51.571 103.142	
5	 231	 50	 6.325	 19535645	 50.100	 100.200	
6	 232	 50	 6.392	 20593911	 52.892	 105.784	
Average	 51.427 102.945	
Standard	deviation		 0.925 1.851	
%	Average	standard	deviation		 1.798 1.798	
	
	
3.	Results	and	discussion	
	
The	 application	 of	 content	 determination	 method	 in	 10	
tablets	 each	 contains	 50	 mg	 ketoprofen	 indicates	 the	
uniformity	of	average	content	49.252	mg/tablet	and	ketoprofen	
content	98.51%(Table	4).	
Based	 on	 the	 uniformity	 test	 of	 content,	 the	 content	
uniformity	 is	 good	enough	since	 the	determination	of	 content	
of	 each	 tablet,	 the	 ketoprofen	 content	 ranges	 from	 93.29	 to	
104.46%	 with	 %average	 deviation	 standard	 =	 4.814	 if	 it	 is	
calculated	with	the	data	of	peak	area	size.	The	value	fulfills	the	
general	 requirement	 of	 content	 uniformity	 of	 quality	 matter	
that	 is	 at	 the	 range	 90‐100%	 with	 %	 average	 deviation	
standard	<	6%.	
The	 result	 of	 ketoprofen	 content	 determination	 in	 tablet	
with	six	replications	can	be	seen	in	Table	5.	
Table	 5	 shows	 that	 the	 average	 ketoprofen	 content	 in	
sample	 tablet	 preparation	 with	 50	 mg/tablet	 based	 on	
chromatogram	 area	 is	 57.472	 ±	 0.925	 mg/tablet	 (%R.S.D.	 =	
1.798).	This	 result	 fulfills	 the	 requirement	 that	 is	90‐110%	of	
the	 table	 of	 good	 precision	 since	 it	 meets	 the	 acceptance	
criteria	<	2%.	
The	test	of	accuracy	includes	the	regaining	of	concentration	
80%	 (98.666‐100.807%),	 concentration	 100%	 (99.073‐
101.795%),	 concentration	 120%	 (99.325‐100.379%)	 all	 meet	
the	criteria.	The	test	of	precision	provides	the	repetitive	value	
less	 than	 2%	 that	 is	 %	 R.S.D.	 for	 each	 concentration	 tested	
1.739%	and	1.949%.	
The	 test	 of	 linearity	 provides	 equation	 line	 that	 is	 y	 =	
236904.255x	+	545295.9	with	the	value	of	detection	limit	(LOD	
=	 0.5302	 ppm	 and	 limit	 of	 quantity	 (LOQ=	 1.7676	 ppm).The	
procedure	of	determining	ketoprofen	content	is	found	in	tablet	
preparation	 using	 HPLC	 Shimadzu	 brand	 version	 6.1	 with	
ethanol	mobile	phase:	phosphate	pH=6	with	comparison	80:20	
(v:v),	 speed	 flow	 1	mL/min,	 using	 Shim‐Pack	 column	 VP‐ODS	
250	x	4.6	mm	at	room	temperature	27	oC	and	automatic	column	
pressure.	
	
4.	Conclusion	
	
Validation	levels	of	ketoprofen	in	tablet	dosage	form	using	
newly	developed	method	is	reliable	and	can	be	used	routinely.	
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